Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy

Molecular Cancer Therapeutics

Volumn 5, Issue 4, 2006, Pages 868-876

  Dumeaux, Vanessa ^a,b,c,d   Johansen, Jostein ^a   Børresen Dale, Anne Lise ^c   Lund, Eiliv ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b INSERM   (France)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MICROARRAY ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RNA EXTRACTION; RNA HYBRIDIZATION;

ADULT; BLOOD CHEMICAL ANALYSIS; CHROMOSOME MAPPING; COHORT STUDIES; DNA; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

EID: 33646576181     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0329     Document Type: Article

References (30)

1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Wang Z, Neuburg D, Li C, et al. Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect 2005;113:233-41.
3. Lampe JW, Stepaniants SB, Mao M, et al. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13:445-53.
4. Whitney AR, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 2003;100:1896-901.
5. Lund E, Kumle M, Braaten T, et al. External validity in a population-based national prospective study-the Norwegian Women and Cancer Study (NOWAC). Cancer Causes Control 2003;14:1001-8.
6. Simon R, Radmacher MD, Dobbin K. Design of studies using DNA microarrays. Genet Epidemiol 2002;23:21-36.
7. Agilent Low RNA Input Fluorescent Linear Amplification Kit Protocol Rev.2.0. 5184-3523. Agilent Technologies 2003. Available from: http://www.agilent.com/chem/supplies.
8. Troyanskaya O, Cantor M, Sherlock G, et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001;17:520-5.
9. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002;99:6567-72.
10. Yang YH, Speed T. Design and analysis of comparative microarray experiments. Chapman & Hall/CRC; 2003. p. 35-91.
11. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
12. Ishwaran H, Rao JP. Detecting differentially expressed genes in microarrays using Bayesian model selection. J Am Stat Assoc 2003;98:438-55.
13. Pavlidis P, Qin J, Arango V, Mann JJ, Sibille E. Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 2004;29:1213-22.
14. Zeeberg BR, Feng W, Wang G, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003;4:R28.
15. Thach DC, Lin B, Walter E, et al. Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 2003;283:269-79.
16. Feezor RJ, Baker HV, Mindrinos M, et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004;19:247-54.
17. Szaniszlo P, Wang N, Sinha M, et al. Getting the right cells to the array: gene expression microarray analysis of cell mixtures and sorted cells. Cytometry A 2004;59:191-202.
18. Debey S, Schoenbeck U, Hellmich M, et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 2004;4:193-207.
19. Rockett JC, Kavlock RJ, Lambright CR, et al. DNA arrays to monitor gene expression in rat blood and uterus following 17β-estradiol exposure: biomonitoring environmental effects using surrogate tissues. Toxicol Sci 2002;69:49-59.
20. Wei C, Li J, Bumgarner RE. Sample size for detecting differentially expressed genes in microarray experiments. BMC Genomics 2004;5:87.
21. Proenza AM, Oliver J, Palou A, Roca P. Breast and lung cancer are associated with a decrease in blood cell amino acid content. J Nutr Biochem 2003;14:133-8.
22. Younan C, Mitchell P, Cumming RG, Panchapakesan J, Rochtchina E, Hales AM. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Am J Epidemiol 2002;155:997-1006.
23. Cumming RG, Mitchell P. Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am J Epidemiol 1997;145:242-9.
24. Klein BE, Klein R, Ritter LL. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 1994;112:85-91.
25. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 2002;102:151-66.
26. Reya T, O'Riordan M, Okamura R, et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 2000;13:15-24.
27. Jin ZX, Kishi H, Wei XC, Matsuda T, Saito S, Muraguchi A. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells. J Immunol 2002;169:3783-92.
28. Eberhard D, Jimenez G, Heavey B, Busslinger M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J 2000;19:2292-303.
29. Johansson AS, Mannervik B. Human glutathione transferase A3 - 3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 2001;276:33061-5.
30. Thompson PA, Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 2000;27:125-34.